RECRUITING

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research is being done to test a new communication tool for people with ovarian cancer, caregivers, and clinicians. The name of the intervention in this research study is: -Collaborative Agenda-Setting Intervention (CASI)

Official Title

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

Quick Facts

Study Start:2025-01-17
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06543537

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * At least 18 years old
  2. * Able to speak, understand, and respond to questions written in English
  3. * Willing to be audio recorded
  4. * Have a diagnosis of advanced ovarian cancer (defined as stage III, stage IV, or recurrent disease)
  5. * Be under the care of a participating clinician dyad
  6. * Be scheduled for chemotherapy during the recruitment period
  7. * Be signed up or willing to sign up for Patient Gateway
  1. * Age of \<18 years
  2. * Unable to consent

Contacts and Locations

Study Contact

Rachel Pozzar, PhD
CONTACT
857-215-0743
Rachel_Pozzar@DFCI.HARVARD.EDU

Principal Investigator

Rachel Pozzar, PhD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Rachel Pozzar, PhD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-17
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-01-17
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Ovarian Cancer
  • Ovarian Neoplasms
  • Ovarian Carcinoma

Additional Relevant MeSH Terms

  • Ovarian Cancer
  • Ovarian Neoplasms
  • Ovarian Carcinoma